Free Trial

genedrive (GDR) Competitors

genedrive logo
GBX 0.60 -0.18 (-22.58%)
As of 12:22 PM Eastern

GDR vs. YGEN, ABDX, PRM, GENI, VRCI, DMTR, LLAI, LLA, IDHC, and DXRX

Should you be buying genedrive stock or one of its competitors? The main competitors of genedrive include Yourgene Health (YGEN), Abingdon Health (ABDX), Proteome Sciences (PRM), GENinCode (GENI), Verici Dx (VRCI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), Integrated Diagnostics (IDHC), and Diaceutics (DXRX). These companies are all part of the "diagnostics & research" industry.

genedrive vs. Its Competitors

Yourgene Health (LON:YGEN) and genedrive (LON:GDR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations and media sentiment.

Yourgene Health has a net margin of -27.55% compared to genedrive's net margin of -1,412.18%. Yourgene Health's return on equity of -27.06% beat genedrive's return on equity.

Company Net Margins Return on Equity Return on Assets
Yourgene Health-27.55% -27.06% -6.71%
genedrive -1,412.18%-191.22%-74.09%

In the previous week, Yourgene Health's average media sentiment score of 0.00 equaled genedrive'saverage media sentiment score.

Company Overall Sentiment
Yourgene Health Neutral
genedrive Neutral

Yourgene Health has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yourgene Health£29.67M0.00-£8.17M-£0.01N/A
genedrive£1.50M2.27-£21.22M-£3.57-0.17

23.3% of Yourgene Health shares are owned by institutional investors. Comparatively, 0.3% of genedrive shares are owned by institutional investors. 64.4% of Yourgene Health shares are owned by insiders. Comparatively, 14.8% of genedrive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Yourgene Health has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, genedrive has a beta of -0.04, meaning that its share price is 104% less volatile than the S&P 500.

Summary

Yourgene Health beats genedrive on 9 of the 10 factors compared between the two stocks.

Get genedrive News Delivered to You Automatically

Sign up to receive the latest news and ratings for GDR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GDR vs. The Competition

MetricgenedriveDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£3.41M£1.16B£5.75B£3.17B
Dividend Yield1.57%5.44%3.95%5.04%
P/E Ratio-0.172.2831.45169.23
Price / Sales2.27475.74428.19465,108.52
Price / Cash2.0011.4237.7527.93
Price / Book0.212.5710.536.89
Net Income-£21.22M£334.07B£3.27B£5.89B
7 Day Performance-26.83%1.61%1.04%0.24%
1 Month Performance-53.38%9.13%5.74%50.01%
1 Year Performance-76.24%3.33%50.88%150.48%

genedrive Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GDR
genedrive
N/AGBX 0.60
-22.6%
N/A-69.7%£3.41M£1.50M-0.1743High Trading Volume
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253
ABDX
Abingdon Health
N/AGBX 6
-4.0%
N/A-45.0%£11.62M£3.84M-14.5984Gap Down
PRM
Proteome Sciences
N/AGBX 2.93
-2.5%
N/A-14.7%£8.63M£10.88B-2.12240Gap Down
GENI
GENinCode
N/AGBX 1.43
+1.8%
N/A-81.3%£2.53M£2.67M-0.422,300
VRCI
Verici Dx
N/AGBX 0.51
-3.8%
N/A-92.5%£1.53M£5.91M-0.2919Gap Down
DMTR
Deepmatter Group
N/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
LLAI
LungLife AI
N/AGBX 3.50
-17.6%
N/A-75.0%£1.16M£33.87K-0.2815Gap Down
High Trading Volume
LLA
LLA.L,0P0001T9GN,0
N/AN/AN/AN/A£0.00N/A-25.0015Gap Down
High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.44
+1.9%
N/A+27.0%£12.95B£23.29T16.356,692
DXRX
Diaceutics
N/AGBX 135
-1.8%
GBX 175
+29.6%
+5.3%£113.93M£26.08M-40.04151

Related Companies and Tools


This page (LON:GDR) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners